The PIA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 1, 2001, Pages 112-115

  Boudoulas, K D ^a   Cooke, G E ^a   Roos, C M ^a   Bray, P F ^a   Goldschmidt Clermont, P J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ESTROGEN; ESTROGEN RECEPTOR; FIBRINOGEN RECEPTOR; FULVESTRANT; GLYCOPROTEIN IIIA; DRUG DERIVATIVE; ESTRADIOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MALE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; ADULT; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; ESTROGEN THERAPY; GENETICS; IN VITRO STUDY; PHYSIOLOGY;

ADULT; CORONARY DISEASE; EPINEPHRINE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN;

EID: 0034746379     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Estrogen and coronary heart disease in women
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
4. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
5. Review articles: Mechanisms of disease: The protective effects of estrogen on the cardiovascular system
6. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
7. Platelet PIA2 polymorphism and thromboembolic events: From inherited risk to pharmacogenetics
8. Increased platelet aggregability associated with platelet GPIIIa PIA2 polymorphism: The Framingham Offspring Study
9. Platelet GP IIIa PI(A) polymorphisms display different sensitivities to agonists
10. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis
11. A2 polymorphism and efficacy of aspirin
12. Refining the treatment of women with unstable angina: A randomized, double-blind, comparative safety and efficacy evaluation of integrelin versus aspirin in the management of unstable angina
13. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity
14. Gender differences in platelet GPIIb-IIIa activation
15. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance
16. A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
17. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
18. Gene frequencies of the five major human platelet antigens in Afro Caribbean, white, and Korean populations
19. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium